Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
211-240 of about 300 reports
About This Report The targeted therapies class boasts several of the top-selling anticancer brands, and has fueled most of the recent rapid growth of the oncology industry as a whole. In the next decade, ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
Global Market Watch With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of ...
This report provides information on the therapeutic development for Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides information on the therapeutic development for Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides information on the therapeutic development for Neutropenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides information on the therapeutic development for Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides information on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
About This Report The targeted therapies class boasts several of the top-selling anticancer brands, and has fueled most of the recent rapid growth of the oncology industry as a whole. In the next decade, ...
Advancements in science and technology have enabled in increasing the number of preserved cord blood units being used in regenerative medicine applications. Expectant parents can decide to store thei ...
This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. The report provides ...
Biocompatibles International Ltd. - Product Pipeline Analysis Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used fo ...
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Emerging cytokine-based therapies, and inhibitors of cytokines and their receptors, represent attractive markets that have become highly competitive. More than 120 companies are developing over 270 new ...
This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Product description The present Competitive Intelligence Report about Her2 and Her3 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) and Her3 receptor targeting molecules ...
Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
This report provides information on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
This report provides information on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
» Download Public Reports
About 1 100 reports
... Biotechnology company. Gfap and nestin are proteins that are co-expressed by certain key cells found in the human central nervous system. Each patent claims a cell culture of undifferentiated gfap+ nestin+ cells ...
» Read our Company Profiles
36 CompaniesReportlinker.com © Copyright 2013. All rights reserved.